Astrid Gosewisch

Dosimetry for 177Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer

Andreas Delker, Wolfgang P. Fendler, Clemens Kratochwil et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 310 citations

Metastatic Prostate Cancer, Urology, Medicine +8

First Clinical Results for PSMA-Targeted α-Therapy Using ²²⁵Ac-PSMA-I&T in Advanced-mCRPC Patients

Mathias J. Zacherl, Franz Josef Gildehaus, Lena M. Mittlmeier et al. · Journal of Nuclear Medicine · 2020 · 172 citations · Full text

Salvage PRRT with 177Lu-DOTA-octreotate in extensively pretreated patients with metastatic neuroendocrine tumor (NET): dosimetry, toxicity, efficacy, and survival

Simon Rudisile, Astrid Gosewisch, Vera Wenter et al. · BMC Cancer · 2019 · 79 citations · Full text

TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis

Lena Vomacka, Nathalie L. Albert, Simon Lindner et al. · EJNMMI Research · 2017 · 63 citations · Full text

Dosimetry and optimal scan time of [18F]SiTATE-PET/CT in patients with neuroendocrine tumours

Leonie Beyer, Astrid Gosewisch, Simon Lindner et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 44 citations · Full text